Jitlada Lapma Austin, NP
Nurse Practitioner · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Stanford Health Care · Permanente Medical Group Inc
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Jitlada Lapma Austin’s office to ask if they take your plan before you enroll.
Drugs they prescribed that Part D paid
$11,774
Pharmacies billed $11,774 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (11 of 347) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.
343 generic and fewer than 11 brand-name prescriptions · $11,774 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Exemestane | 48 | $3,901 | $81 |
| Anastrozole | 97 | $2,693 | $28 |
| Letrozole | 84 | $1,865 | $22 |
| Gabapentin | 19 | $244 | $13 |
Year by year
| 2024 | 347 | 150 | 3% (11) | None | $11,774 |
| 2023 | 373 | 175 | 8% (29) | 22% | $714,500 |
| 2022 | 572 | 191 | 5% (27) | 21% | $944,498 |
| 2021 | 439 | 200 | 3% (11) | 14% | $536,041 |
| 2020 | 153 | 70 | None | 16% | $91,793 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Abiraterone Acetate | 13 | $96,018 | $7,386 |
| Xarelto | 29 | $19,581 | $675 |
| Letrozole | 15 | $476 | $32 |
| Acyclovir | 14 | $441 | $31 |
| Anastrozole | 20 | $431 | $22 |
| Hydrocodone-Acetaminophen | 12 | $409 | $34 |
| Omeprazole | 15 | $218 | $15 |
| Prednisone | 12 | $87 | $7 |
2022: 18 drugs
| Revlimid | 12 | $200,446 | $16,704 |
| Xarelto | 41 | $31,235 | $762 |
| Eliquis | 16 | $18,008 | $1,126 |
| Ondansetron | 23 | $1,355 | $59 |
| Lidocaine-Prilocaine | 41 | $982 | $24 |
| Dexamethasone | 18 | $603 | $33 |
| Hydrocodone-Acetaminophen | 19 | $485 | $26 |
| Hydroxyurea | 20 | $452 | $23 |
| Acyclovir | 24 | $444 | $19 |
| Letrozole | 24 | $380 | $16 |
| Potassium Chloride | 18 | $353 | $20 |
| Anastrozole | 12 | $346 | $29 |
| Prednisone | 38 | $276 | $7 |
| Omeprazole | 25 | $263 | $11 |
| Loperamide | 12 | $258 | $21 |
| Prochlorperazine Maleate | 24 | $229 | $10 |
| Gabapentin | 11 | $113 | $10 |
| Pantoprazole | 11 | $50 | $5 |
2021: 11 drugs
| Xarelto | 11 | $12,677 | $1,152 |
| Exemestane | 12 | $3,344 | $279 |
| Letrozole | 29 | $1,169 | $40 |
| Anastrozole | 27 | $783 | $29 |
| Hydroxyurea | 13 | $626 | $48 |
| Dexamethasone | 24 | $603 | $25 |
| Lidocaine-Prilocaine | 20 | $399 | $20 |
| Prednisone | 23 | $220 | $10 |
| Ondansetron | 13 | $208 | $16 |
| Acyclovir | 12 | $175 | $15 |
| Prochlorperazine Maleate | 18 | $171 | $10 |
2020: 3 drugs
| Lidocaine-Prilocaine | 42 | $794 | $19 |
| Prochlorperazine Maleate | 22 | $257 | $12 |
| Ondansetron | 12 | $133 | $11 |
Money from drug and device companies
$43 in 2025
| 2025 | 1 | 1 | None | $43 |
| 2024 | 2 | 2 | None | $53 |
| 2023 | 18 | 27 | None | $691 |
| 2022 | 36 | 111 | None | $2,493 |
| 2021 | 28 | 83 | None | $1,793 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Enhertu | $43 | 1 payment
|
See the published payment
| AstraZeneca Pharmaceuticals LP | Education · 2025-11-25 | Enhertu | $43 |
See earlier years (2024, 2023, 2022, 2021)
2024: $53
| Eisai | Lenvima | $28 | 1 payment
|
| GlaxoSmithKline | Jemperli | $25 | 1 payment
|
2023: $691
| Celgene | Reblozyl | $81 | 3 payments
|
| Seagen | Padcev | $72 | 2 payments
|
| Pharmacyclics LLC An AbbVie | Imbruvica | $68 | 3 payments
|
| Novartis Pharmaceuticals | Tabrecta | $58 | 3 payments
|
| Janssen Biotech | Erleada | $46 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Imfinzi | $44 | 2 payments
|
| Genentech USA | Lunsumio | $33 | 1 payment
|
| Eisai | Lenvima | $32 | 1 payment
|
| Organon | Ontruzant | $30 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Ninlaro | $29 | 1 payment
|
| Sumitomo Pharma America | Orgovyx | $29 | 1 payment
|
| Lilly USA | Verzenio | $28 | 1 payment
|
| Incyte | Pemazyre | $26 | 1 payment
|
| Puma Biotechnology | None | $25 | 1 payment
|
| Pfizer | Ibrance | $23 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Opdivo | $23 | 1 payment
|
| Gilead Sciences | Trodelvy | $21 | 1 payment
|
| Amgen | Lumakras | $21 | 1 payment
|
2022: $2,493
| Astellas Pharma US | Padcev | $231 | 4 payments
|
| Janssen Biotech | Darzalex | $210 | 11 payments
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $165 | 8 payments
|
| Myovant Sciences | Orgovyx | $134 | 5 payments
|
| Seagen | Adcetris | $130 | 4 payments
|
| Celgene | Pomalyst | $124 | 7 payments
|
| Merck Sharp & Dohme | Keytruda | $113 | 5 payments
|
| Novartis Pharmaceuticals | Promacta | $105 | 5 payments
|
| Amgen | Lumakras | $103 | 4 payments
|
| E.R. Squibb & Sons L.L.C. | Opdivo | $103 | 5 payments
|
| Lilly USA | Verzenio | $97 | 4 payments
|
| Pfizer | Xtandi | $96 | 4 payments
|
| Taiho Oncology | Lonsurf | $89 | 5 payments
|
| Takeda Pharmaceuticals U.S.A. | Ninlaro | $86 | 4 payments
|
| Genzyme | Jevtana | $73 | 2 payments
|
| Eisai | Lenvima | $68 | 3 payments
|
| Pharmacyclics LLC an AbbVie | Imbruvica | $58 | 3 payments
|
| Sobi | Doptelet | $46 | 2 payments
|
| Puma Biotechnology | Nerlynx | $46 | 2 payments
|
| Array Biopharma | Braftovi | $45 | 2 payments
|
| Incyte | Jakafi | $36 | 2 payments
|
| Immunocore | Kimmtrak | $33 | 1 payment
|
| Daiichi Sankyo | Enhertu | $28 | 1 payment
|
| AVEO Pharmaceuticals | Fotivda | $26 | 1 payment
|
| Exelixis | Cabometyx | $25 | 1 payment
|
| BeiGene USA | Brukinsa | $24 | 1 payment
|
| Organon | Ontruzant | $24 | 1 payment
|
| Global Blood Therapeutics | Oxbryta | $22 | 1 payment
|
| Regeneron Healthcare Solutions | Libtayo | $22 | 1 payment
|
| CTI BioPharma | Vonjo | $22 | 1 payment
|
| Tactile Systems Technology | Flexitouch Plus | $21 | 1 payment
|
| Kyowa Kirin | Poteligeo | $21 | 1 payment
|
| ADC Therapeutics America | None | $20 | 1 payment
|
| Epizyme | Tazverik | $20 | 1 payment
|
| Rigel Pharmaceuticals | Tavalisse | $14 | 1 payment
|
| Heron Therapeutics | Sustol | $14 | 1 payment
|
2021: $1,793
| Amgen | Lumakras | $402 | 12 payments
|
| Merck Sharp & Dohme | Keytruda | $166 | 8 payments
|
| Takeda Pharmaceuticals U.S.A. | Ninlaro | $149 | 11 payments
|
| Seagen | Tukysa | $128 | 6 payments
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $104 | 5 payments
|
| Eisai | Lenvima | $91 | 4 payments
|
| Lilly USA | Cyramza | $79 | 5 payments
|
| Novartis Pharmaceuticals | Lutathera | $73 | 4 payments
|
| E.R. Squibb & Sons L.L.C. | Opdivo | $57 | 3 payments
|
| Myovant Sciences | Orgovyx | $56 | 2 payments
|
| Pharmacyclics LLC An AbbVie | Imbruvica | $47 | 2 payments
|
| Daiichi Sankyo | Enhertu | $46 | 2 payments
|
| Epizyme | Tazverik | $43 | 2 payments
|
| Genzyme | Libtayo | $43 | 2 payments
|
| Karyopharm Therapeutics | Xpovio | $28 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Cosela | $27 | 2 payments
|
| Alexion Pharmaceuticals | Ultomiris | $27 | 1 payment
|
| Pfizer | Inlyta | $26 | 1 payment
|
| Puma Biotechnology | Nerlynx | $25 | 1 payment
|
| Astellas Pharma US | Xospata | $23 | 1 payment
|
| Clovis Oncology | None | $23 | 1 payment
|
| RedHill Biopharma | Aemcolo | $22 | 1 payment
|
| Blueprint Medicines | Ayvakit | $21 | 1 payment
|
| Organon | Ontruzant | $21 | 1 payment
|
| Janssen Biotech | Erleada | $20 | 1 payment
|
| AMAG Pharmaceuticals | Feraheme | $18 | 1 payment
|
| Acrotech Biopharma | Hemady | $17 | 1 payment
|
| BeiGene USA | Brukinsa | $14 | 1 payment
|
Professional record
- NPI
- 1730743345
- Licence
- CA 95011604
- Group
- Stanford Health Care · Permanente Medical Group Inc
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Nurse practitioner (363L00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2019-04-29
- NPI last updated
- 2026-02-17
- NPI record certified
- 2026-02-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 5555 W Las Positas Blvd, Pleasanton, CA, 94588 · 5725 W Las Positas Blvd Ste 100a, Pleasanton, CA, 94588